⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

MetLife MET

United States Financial Services
5.5/10
AI Analyst score
97.70 USD
Last price at analysis date · analyst target 105.75 (+8.2%)
🛒 Where to buy METPartner brokers · US (NYSE/Nasdaq) · sample 200.00 € orderUS (NYSE/Nasdaq)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold or accumulate: the tailwind of high rates and reasonable valuation support the thesis, although quality (operating margin 5.52%) and ROA (0.45%) limit upside potential.

MetLife is a global life and health insurer offering life, accident, and health insurance, as well as retirement and asset management products through a diversified distribution network. MetLife presents solid financial health (ROE 13.09) and revenue growth of 10.50%, with an attractive valuation (forward P/E 8.94) that benefits from the high-rate environment in the US, which widens the intermediation margin of its investment portfolio.

Financial health
4.9
Quality / Moat
3.2
Valuation
4.2
Growth
6.4
Dividend
7.0
Momentum
6.3
Risk & Context
8.0

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E18.72
Fwd P/E8.94
EV/EBITDA14.17
P/B2.27
P/S0.78
PEG0.52
Market cap62.09 B USD
Enterprise value85.60 B USD
🏰 Quality and moat
ROIC (approx.)5.6%
Gross margin23.95%
FCF conversion-347%
Operating margin5.52%
📈 Profitability and margins
ROE13.09%
ROA0.45%
Net margin4.57%
FCF-20.95 B USD
FCF yield-33.75%
🏦 Solvency and liquidity
Total debt50.31 B USD
Net debt22.99 B USD
Cash27.32 B USD
EBITDA6.04 B USD
Net debt / EBITDA3.81
D/E179.93
Current ratio2.03
Quick ratio1.71
🚀 Growth
Revenue growth10.50%
Earnings growth5.80%
EPS (TTM)5.22 USD
EPS (Fwd)10.92 USD
💰 Dividend and risk
Dividend yield2.43%
Payout44.0%
Beta0.76
Analyst consensusBuy (16)
Target price105.75 USD
52-week range67.33 USD – 100.93 USD
⚠️ Main risk: The main risk is the sensitivity of the investment portfolio to a sharp change in rates: if the Fed cuts sooner than expected, the return on the bond portfolio compresses and the intermediation margin narrows, affecting financial health.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

MetLife is a global life and health insurer offering life, accident, and health insurance, as well as retirement and asset management products through a diversified distribution network. MetLife presents solid financial health (ROE 13.09) and revenue growth of 10.50%, with an attractive valuation (forward P/E 8.94) that benefits from the high-rate environment in the US, which widens the intermediation margin of its investment portfolio.

Score by category

CategoryScore
Financial health4.9
Quality / Moat3.2
Valuation4.2
Growth6.4
Dividend7.0
Momentum6.3
Risk & Context8.0

OVERALL SCORE: 5.5/10

Context and risks

The rise in US Treasury yields to 5.17% is a structural tailwind for MetLife: as a life insurer, its bond portfolio gains in yield and widens the intermediation margin. The effect is positive and material, given the size of its investment portfolio.

News considered in the analysis

  • VOYA's Improving Employee Benefits Business Drives Earnings Growth — Noticia sobre un competidor (Voya), sin información nueva sobre MetLife.
  • 3 US Insurer Stocks Whose Bond Portfolios Matter More at 5% Treasury Yields — El contexto de tipos al 5% en EE.UU. es material para aseguradoras de vida: mejora el retorno de la cartera de inversión y el margen de intermediación, un viento a favor para MetLife.
  • Creatio commits $300m to scale financial AI — Noticia sobre una empresa de software, sin relación directa con MetLife.
  • Danny Meyer Has Opened Many Hit Restaurants. What He Learned By Closing One. — Artículo de restauración, irrelevante para MetLife.
  • Can MetLife's Group Benefits Segment Maintain Its Momentum? — Análisis sobre la sostenibilidad del crecimiento en beneficios de grupo; sugiere fortaleza pero con interrogantes, sin hechos nuevos confirmados.

Verdict: Hold or accumulate: the tailwind of high rates and reasonable valuation support the thesis, although quality (operating margin 5.52%) and ROA (0.45%) limit upside potential.

Main risk: The main risk is the sensitivity of the investment portfolio to a sharp change in rates: if the Fed cuts sooner than expected, the return on the bond portfolio compresses and the intermediation margin narrows, affecting financial health.

Other Financial Services companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.